PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

227 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
61.
Asadpour, R.* ; Pigorsch, S.U.* & Combs, S.E.: Unexpected discontinuations in patients undergoing radiotherapy. Strahlenther. Onkol. 195, S134-S134 (2019)
62.
Bicher, S. et al.: Biologically inspired nanoparticles as tools for the protection of healthy tissues in radiotherapy. Strahlenther. Onkol. 195, S165-S165 (2019)
63.
Borm, K.J.* et al.: The influence of hypofractionation on the incidental irradiation of the axillary lymphatic pathways of patients with breast cancer. Strahlenther. Onkol. 195, S21-S21 (2019)
64.
Dapper, H.* et al.: Have we achieved optimal Recommendations for the Target Volume Definition for Patients with Anal Cancer? A PET-based Analysis of the initial Lymph Node Distribution in Patients with Anal Cancer. Strahlenther. Onkol. 195, S9-S9 (2019)
65.
Diehl, C. et al.: Neoadjuvant radiotherapy (N-RT) for intracebral metastases of solid tumors (NepoMUC): A phase I dose escalation trial. Strahlenther. Onkol. 195, S117-S117 (2019)
66.
Dobiasch, S. et al.: Histopathological validation of the accuracy of high-precision stereotactic irradiation in an orthotopic pancreatic tumor mouse model. Strahlenther. Onkol. 195, S172-S172 (2019)
67.
Eidemüller, M. ; Holmberg, E.* ; Lundell, M.* & Karlsson, P.*: Increased risk of breast cancer from radiation in the presence of familial breast cancer history: Results from the Swedish hemangioma cohort and implications for breast cancer radiotherapy. Strahlenther. Onkol. 195, S81-S81 (2019)
68.
Fischer, J.C.* et al.: No improved Regeneration after radiogenic and immunopathogenic Tissue Damage by Type III Interferon Activation. Strahlenther. Onkol. 195, S166-S166 (2019)
69.
Gerhardt, A.S.* et al.: Simulation of the Influence of Rotational Errors on the Dose in PTV and Risk Organs during the Storage for cranial Radiotherapy. Strahlenther. Onkol. 195, S108-S108 (2019)
70.
Hess J. et al.: A five-microRNA-signature predicts recurrence and survival in HPV-negative HNSCC. Strahlenther. Onkol. 195, S25-S25 (2019)
71.
Kern J.* et al.: Identification of Biomarkers for the Determination of individual Radiosensitivity in Patients with pancreatic ductal Adenocarcinoma. Strahlenther. Onkol. 195, S172-S172 (2019)
72.
Kessel, C. et al.: A five-year report on the MSc radiation biology at the technical University of Munich (TUM). Strahlenther. Onkol. 195, S192-S192 (2019)
73.
Kessel, K.A. et al.: Influence of PET imaging during the radiotherapy planning on the survival of meningioma patients. Strahlenther. Onkol. 195, S113-S113 (2019)
74.
Kessel, K.A. et al.: Is fractional stereotactic radiation therapy (FSRT) superior to radiosurgery (RC) for the treatment of resection hollow in patients with brain metastases? Strahlenther. Onkol. 195, S113-S114 (2019)
75.
Kessel, K.A. ; Weber, W.* ; Zimmer, C.* ; Meyer, B.* & Combs, S.E.: Development of a prognostic score for the outcome after resection and radiotherapy in patients with high-grade meningioma (WHO II/III). Strahlenther. Onkol. 195, S34-S34 (2019)
76.
Kessler, C.* et al.: Characterization of the radiation response of different patient-derived organoids of pancreatic cancer. Strahlenther. Onkol. 195, S41-S42 (2019)
77.
Kirstein, A. et al.: Influence of MGMT expression on the radiation response in different Glioblastoma multiforme cell lines. Strahlenther. Onkol. 195, S162-S163 (2019)
78.
Klymenko, O. et al.: Patient-derived HNSCC cell lines and subclones reflect inter- and intra-tumoral heterogeneity regarding genomic copy number alterations and radiation response. Strahlenther. Onkol. 195, S75-S76 (2019)
79.
Kokowski, K.* et al.: Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in apatient with NSCLC stage IIIb inducing long-term tumor control: Acase study. Strahlenther. Onkol. 195, 352-361 (2019)
80.
Kraus, K.M.* & Combs, S.E.: Zweitmalignomrisiko nach Behandlung von lokal begrenzten Prostatakarzinomen mit Kohlenstoffionen möglicherweise niedriger als nach Photonenbestrahlung. Strahlenther. Onkol. 195, 1033-1035 (2019)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... ▶▶ ▶▮